NHS England pulling the plug on PrEP for HIV prevention is unacceptable
I wish to draw your attention to NHS England’s sudden abandonment of its own processes in a shocking U-turn on access to HIV game changer pre-exposure prophylaxis (PrEP; emtricitabine/tenofovir, marketed as Truvada).
The HIV sector has been waiting for the announcement of the first ever …